JONATHAN PENDER: Open Payments
NPI 1285052720 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 28 payments from 14 companies in 2025. Trend: 2023 $961 · 2024 $702 · 2025 $813
Food & beverage: $753Education: $60
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $164 |
| ABBVIE INC. | 9 | $152 |
| GENZYME CORPORATION | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 4 | $115 |
| Inspire Medical Systems, Inc. | 1 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| AERIN MEDICAL INC. | 1 | $24 |
| Greer Laboratories, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| ALK-Abello, Inc | 1 | $22 |
Products named: DUPIXENT, AIRSUPRA, QULIPTA, INSPIRE, ELAPRASE, UBRELVY, VIVAER STYLUS, ORALAIR.
Industry payments across VA — which companies pay providers there.
